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A B S T R A C T
Ferulic acid is a ubiquitous phytochemical that holds enormous therapeutic potential but has not gained
much consideration in biomedical sector due to its less bioavailability, poor aqueous solubility and
physiochemical instability. In present investigation, the shortcomings associated with agro-waste
derived ferulic acid were addressed by encapsulating it in electrospun nanoﬁbrous matrix of poly (D,L-
lactide-co-glycolide)/polyethylene oxide. Fluorescent microscopic analysis revealed that ferulic acid
predominantly resides in the core of PLGA/PEO nanoﬁbers. The average diameters of the PLGA/PEO and
ferulic acid encapsulated PLGA/PEO nanoﬁbers were recorded as 125  65.5 nm and 150  79.0 nm,
respectively. The physiochemical properties of fabricated nanoﬁbers are elucidated by IR, DSC and NMR
studies. Free radical scavenging activity of fabricated nanoﬁbers were estimated using di(phenyl)-(2,4,6-
trinitrophenyl)iminoazanium (DPPH) assay. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) assay conﬁrmed the cytotoxicity of ferulic acid encapsulated nanoﬁbers against
hepatocellular carcinoma (HepG2) cells. These ferulic acid encapsulated nanoﬁbers could be potentially
explored for therapeutic usage in biomedical sector.
ã 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Recently, there has been an emerging research interest is
noticed in renaissance of naturally occurring phenolic compounds
as a potential therapeutic agents against broad range of inﬁrmities
including cancer, diabetes, aging, cardiovascular and neurodegen-
erative disease [1–3]. Among the naturally occurring polyphenolic
plant constituent, ferulic acid possess a wide range of biomedical
effects including antioxidant, anti-inﬂammatory, antimicrobial,
antiallergic, anticarcinogenic, antithrombotic, antiviral, hepato-
protective, and vasodilatory actions [4–6]. Ferulic acid has also
been approved globally as food additive to prevent the peroxida-
tion of lipids as it affectively scavenges the superoxide anion
radical [7,8]. However, despite the broad range of bioactivities, the
therapeutic applications of ferulic acid are limited due to its poor
bioavailability, low water solubility and physiochemical instability
in human body ﬂuids [9,10]. The conjugation of such bioactive
molecules with biodegradable and biocompatible polymeric
matrix, improves the water solubility of drug molecules due to
the presence of interactions between drug and polymer matrix.* Corresponding author. Fax: +91 1332 286151.
E-mail addresses: vikasfbs@iitr.ernet.in, vikasfbs@gmail.com (V. Pruthi).
http://dx.doi.org/10.1016/j.btre.2015.08.008
2215-017X/ã 2015 Published by Elsevier B.V. This is an open access article under the CPolymeric matrix provides an environment to the drug in which
dispersed drug molecules can reside and experience the interme-
diate mobility and solubility as compare to pure components [11].
This in turn results into advanced pharmacokinetics properties as
well as reduced side effects of drug [12,13]. A number of
approaches have been introduced to formulate such systems
which consists of biodegradable polymers along with antioxidant
compound in order to improve the safety, therapeutic efﬁcacy,
stability and reduce toxicity by delivering the drug in a sustained
manner for a prolong period [10,14]. In this investigation, we used
electrospinning approach to encapsulate agro-waste derived
ferulic acid in PLGA/PEO polymeric nanoﬁbrous matrix to combat
the shortcomings associated with it. These ferulic acid encapsu-
lated nanoﬁbers were then evaluated for its antioxidant and
cytotoxic potential against HepG2 cells.
2. Materials and methods
2.1. Materials
Ferulic acid was isolated from Parthenium hysterophorus plant
which was locally obtained and its identiﬁcation was authenticat-
ed by Forest Research Institute (FRI), Dehradun, India. The
polymers, PLGA (Mw45,000) and PEO (Mw900,000) wereC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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methane (DCM), N,N-dimethylformamide (DMF), 3-(4,5-dime-
thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), cell
culture-grade dimethyl sulfoxide (DMSO), phosphate buffer saline
(PBS), di(phenyl)-(2,4,6-trinitrophenyl)iminoazanium (DPPH) as-
say kit, acridine orange (AO), ethidium bromide (EtBr), Dulbecco’s
Modiﬁed Eagle Medium (DMEM) and all analytical grade chemicals
were procured from Himedia (India). Human hepatoma cell line
(HepG2) was obtained from National Center for Cell Science
(NCCS), India.
2.2. Extraction and characterization of ferulic acid
Plant sample (whole plant) was dried under sunlight and kept
in oven at 40 C for 12 h. The dried samples were grounded to
powder for the extraction of ferulic acid as described earlier
[15,16]. Brieﬂy, 2.0 g powder of plant sample was taken in 250 mL
round bottom ﬂask containing 60 mL NaOH (2 M). To prevent the
oxidation of ferulic acid during alkali treatment, 0.001 g NaHSO3
was added and kept within rotary shaker at 25 C, 180 rpm for 24 h.
Sample was then centrifuged at 12,000 rpm for 10 min and the
obtained supernatant was acidiﬁed with by 2 M HCl solution
(pH  2). Acidiﬁed sample was treated three times with 60 mL
ethyl acetate and concentrated for the extraction of ferulic acid.
The concentrated extract was dissolved in equal volume of
acetonitrile/water for further analysis [17]. Ferulic acid bands
from TLC plate was scraped and dissolved in 2.0 mL acetonitrile.
The samples (n = 3) were quantitative analyzed using HPLC
(Knauer, Germany) with C18 column having mobile phase
consisting of acetonitrile/water (80:20) and 0.1% acetic acid and
absorbance was taken at 320 nm.Fig. 1. FESEM and ﬂuorescent micrographs of PLGA/PEO (a and b) and ferulic acid (FA) en
histograms.2.3. Preparation of electrospun nanoﬁbers
Polymers (PLGA:PEO:1:1) at an absolute concentration of 2 wt%
were dissolved in DCM/DMF (4:1, v/v) solvent to prepare PLGA/PEO
nanoﬁbers. A blended solution containing ferulic acid and PLGA/
PEO polymers was prepared by dissolving ferulic acid (2 mg/mL) in
the above prepared 2 wt% PLGA/PEO polymeric solution. PLGA/PEO
and ferulic acid containing PLGA/PEO solutions were then
separately loaded into a 5.0 mL syringe which is attached to a
metallic needle (21 G). Electrospinning process was performed at a
ﬁxed applied voltage (18 kV) and solution ﬂow rate (0.5 mL/h). The
fabricated nanoﬁbers were collected on aluminum foil collector,
placed at 12 cm horizontal distance from the metallic needle tip.
The collected nanoﬁbers were placed in desiccators for 24 h to get
rid of any residual solvent.
2.4. Spectroscopic and microscopic analysis
Infrared absorption of isolated ferulic acid, PLGA/PEO and
ferulic acid encapsulated PLGA/PEO nanoﬁbers were examined by
infrared (IR) spectrometer (Thermo Nicolet Nexus 6700, US) while
nuclear magnetic resonance (NMR) experiments were performed
using 500 MHz high resolution NMR spectrometer (Avance
500 Bruker Biospin Intl. AG, Switzerland). The phase behavior of
samples (10–12 mg) was observed by heating them at 10 C/min
from 25 to 500 C under the nitrogen atmosphere using a
differential scanning calorimeter (DSC; EXSTAR TG/DTA 6300).
Morphology of fabricated nanoﬁbers was observed using ﬁeld
emission scanning electron microscopy (FESEM; Quanta 200F
Model, FEI, Netherland) at an accelerated voltage of 15 kV. Samples
for FESEM were prepared by cutting them into 1 1 cm pieces and
sputter coated with gold for 1 min using a Biotech SC005 sputter
coater. The diameter of nanoﬁbers was measured from FESEMcapsulated PLGA/PEO (c and d) nanoﬁbers with corresponding diameter distribution
Fig. 2. IR spectra and of isolated (a) ferulic acid (b) PLGA/PEO and (c) ferulic acid encapsulated PLGA/PEO nanoﬁbers.
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the ferulic acid encapsulation in the PLGA/PEO nanoﬁbers were
also illustrated by ﬂuorescent microscopy. For sample preparation,nanoﬁbers were collected onto a glass cover slip for 2 min and
observed immediately under the microscope (Evosﬂ, AMG groups,
USA).
Fig. 3. 1H NMR spectra of isolated (a) ferulic acid (b) PLGA/PEO and (c) ferulic acid encapsulated PLGA/PEO nanoﬁbers.
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The antioxidant activity of ferulic acid before and after
encapsulation was measured using DPPH radical-scavenging assay
as reported earlier [14]. Brieﬂy, 0.2 mL solution containing ferulic
acid encapsulated PLGA/PEO nanoﬁbers (10 mg in 5 mL DCM/DMF;
n = 3) was added in 2.8 mL of 1 104M methanol solution of DPPH
radical and allowed to stand in dark at room temperature for
60 min. Similarly, the equivalent amount of ferulic acid (2 mg/mL)
in PLGA/PEO solution before electrospinning was used as control
and assayed for comparative study. The absorbance was recorded
at 517 nm.
2.6. In vitro cytotoxic activity against HepG2 cells
In vitro cell viability of HepG2 cells on ferulic acid encapsulated
PLGA/PEO nanoﬁbers was estimated using MTT assay [18]. Brieﬂy,
the sterilized electrospun samples (n = 3) were kept in 24 well
microtiter plates and DMEM medium supplemented with 10% fetal
bovine serum (FBS) was added to each well. Diluted suspension of
HepG2 cells (1 105 cells/mL) was then added to each well andTable 1
Change in chemical shifts (ppm) in 1H NMR of isolated ferulic acid and ferulic acid en
Type of protons Isolated ferulic acid 
OCH3 3.6 ppm 
Aromatic 6.3–7.7 ppm 
Phenolic 9.4 ppm 
Carboxylic 11.92 ppm plates were incubated in humidiﬁed atmosphere containing 5%
CO2 at 37 C in a CO2 incubator. The HepG2 cells cultured in
presence of isolated ferulic acid only were used as positive control.
Cells were harvested after 24 h and washed carefully with PBS (pH
7.4) to remove unattached cells. FESEM was used to observe the cell
morphologies on each sample. For FESEM imaging, the adhered
cells on samples were secured by keeping them in 2.5%
glutaraldehyde/PBS solution at 4 C for 4 h. Consequently, the
samples were desiccated stepwise with different graded ethanol
solutions (25%, 50%, 75%, 90% and 100%) and coated with gold.
2.7. Cytotoxic analysis using ﬂuorescent microscopy
HepG2 cells (1 105 cells/mL) cultured in presence of different
formulations (as described above) were stained with acridine
orange (AO) and ethidium bromide (EtBr) (100 mg/mL stock
solution) for 10 min in order to determine the cell death type.
The stained cells seeded on fabricated nanoﬁbrous samples were
than observed under the ﬂuorescence microscope (Evosﬂ, AMG
groups, USA).capsulated PLGA/PEO nanoﬁbers.
Ferulic acid encapsulated
PLGA/PEO nanoﬁbers
Change in chemical
shift (ppm)
3.8 ppm +0.2
6.8–8.3 ppm +0.5–0.6
9.8 ppm +0.4
12.05 ppm +0.13
Fig. 4. DSC thermograms of isolated ferulic acid (FA), PLGA/PEO and ferulic acid encapsulated PLGA/PEO nanoﬁbers (PLGA/PEO-FA).
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The experiments were performed in triplicate (n = 3) and the
results are expressed as mean values with standard deviation
(SD). Statistical analysis was performed using one-way ANOVA
test. Statistical signiﬁcance values of p < 0.05 were considered.Fig. 5. Antioxidant activity of ferulic acid (FA) before and after encapsulation
(electrospinning).3. Results and discussion
3.1. Extraction and characterization of isolated ferulic acid
Isolation and quantiﬁcation of ferulic acid from P. hysterophorus
sample were carried out using alkali treatment and chro-
matographic techniques, respectively. The TLC chromatogram of
plant sample indicated the presence of ferulic acid when sprayed
with 10% ferric chloride solution and compared with standard
ferulic acid (Supplementary Fig. 1). HPLC assessment of TLC spots
for ferulic acid (retention time: 29.07 min) was performed for
further puriﬁcation (Supplementary Fig. 2). The approximate
content of ferulic acid in whole plant was recorded to be 145–
160 mg/100gram (45–50 mg, 64–70 mg and 32–35 mg in root, stem
and leaves, respectively).
3.2. Morphology of electrospun nanoﬁbers
Key parameters (polymer concentration, ferulic acid concen-
tration, applied voltage, solution ﬂow rate and tip to collector
distance) that affect the ﬁber morphology were optimized for
successful preparation of the ferulic acid encapsulated nanoﬁbers
as described earlier [19,20]. FESEM analysis depicted the average
diameter of nanoﬁbers as 125  65.5 nm and 150  79.0 nm for
ferulic acid-free PLGA/PEO and ferulic acid encapsulated PLGA/PEO
nanoﬁbers, respectively (Fig. 1a and b). The surface of nanoﬁbers
appeared smooth and free of ferulic acid crystal on the ﬁbrous
surface. Data depicts that ferulic acid homogenously dispersed in
the nanoﬁbers with slight enhancement in the ﬁber diameter as
shown in their corresponding diameter distribution histograms
(Fig. 1). The encapsulation of ferulic acid within the nanoﬁbers was
further assessed using auto-ﬂuorescence properties of ferulic acid
(Fig. 1b and d). The intersectional ﬂuorescent images represent
Fig. 6. Colorimetric MTT viability assay against HepG2 cells treated with different formulations coverslips (control), PLGA/PEO nanoﬁbers, native ferulic acid and ferulic acid
encapsulated PLGA/PEO nanoﬁbers after 24 h at A570 nm. Error bars represent mean  standard deviation for three independent experiments (n = 3). Nfs = nanoﬁbers.
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encapsulated PLGA/PEO nanoﬁbers.
3.3. Spectroscopic and thermal analysis
The successful incorporation as well as the presence of the
secondary interactions between ferulic acid and nanoﬁbers has
been conﬁrmed by IR (Fig. 2) and NMR spectroscopy (Fig. 2B,
500 MHz, solvent: CDCl3). The presence of secondary interactions
reﬂected the compatibility among the drug molecules and carrier
nanoﬁbrous matrix. The IR spectrum of isolated ferulic acid
showed the characteristic bands at 3437.43 cm1 for OH group,
3015.70 cm1 for CH group, 1690.52 cm1 for C¼O group,
1665.06 cm1 for alkene group, 1619.97–1431.54 cm1 for C¼C
group, 1272.94–1234.36 cm1 for COC group and from 900 to
650 cm1 for CH group. The IR data obtained for ferulic acid
was found to be in agreement with the earlier reports [21,22]. The
IR spectrum for PLGA/PEO nanoﬁbers shown peaks at 3436 cm1
(OH group), 2922–2856 cm1 (CH vibrations), 2360 cm1
(CRC group), 1760–1630 cm1 (C¼O group) and 1271–
1100 cm1 (CO group). The IR spectrum for ferulic acid
encapsulated PLGA/PEO nanoﬁbers contained all the peaks for
PLGA/PEO ﬁbers as well as for ferulic acid. In addition, the
spectrum of ferulic acid encapsulated nanoﬁbers also showed the
shifting of absorption peaks (1640–1820 cm1) to lower wave-
number which possibly could be due to the presence of weak
interactions such as hydrogen bonding between the PLGA/PEO
carbonyl groups and ferulic acid hydroxyl groups. The shifting of
peaks and presence of the ferulic acid peaks in the IR spectra of the
composite nanoﬁbers conjointly suggested the interaction be-
tween the ferulic acid and polymeric matrix which ensures a
stabilized environment for the composite structure and provides ahigh degree of compatibility between the components of nano-
ﬁbers.
The stability studies were performed using NMR to examine the
stability of ferulic acid after encapsulation due to its peculiar
instability [23]. 1H NMR spectrums of isolated ferulic acid, PLGA/
PEO nanoﬁbers and ferulic acid encapsulated PLGA/PEO nanoﬁbers
displayed no considerable difference for the peaks of ferulic acid
(Fig. 3) thereby indicating the integrity of ferulic acid molecules
and the retention of its activity even after electrospinning process.
In addition, small peaks (ranges from 6.3–7.7 ppm) for ferulic acid
in the NMR spectrum of ferulic acid encapsulated PLGA/PEO
nanoﬁbers have been found to be slightly shifted towards 6.8 ppm
to 8.3 ppm and the methoxy group has been shifted from 3.6 ppm
to 3.8 ppm after encapsulation.
The variation in chemical shifts variation which occurred after
encapsulation of isolated ferulic in PLGA/PEO nanoﬁbers has been
listed in Table 1. This shifting could be attributed to the presence of
weak interaction bonds such as hydrogen bonds between the
ferulic acid and polymeric matrix.
The phase transition behavior and physical stability of isolated
ferulic acid, ferulic acid free and ferulic acid encapsulated
nanoﬁbers were evaluated by DSC analysis (Fig. 4). DSC thermo-
grams of isolated ferulic acid exhibited a single sharp endothermic
peak at melting point of 173 C whereas thermograms of PLGA/PEO
nanoﬁbers showed ﬁrst endothermic peak due to glass transition
temperature (Tg) at 65 C and a second endothermic peak at 318 C
due to the melting of crystalline phase of polymeric matrix [24–
26]. In case of ferulic acid encapsulated nanoﬁbers melting
temperature point was shifted to the lower values compared to
isolated ferulic acid (173–151 C). This shifting could be attributed
to the improved orientation in the molecular chains of encapsu-
lated ferulic acid and large surface area to volume ratio of
42 P. Vashisth et al. / Biotechnology Reports 8 (2015) 36–44nanoﬁbers. The decrease in the melting point could also be
observed due to the presence of amorphous ferulic acid in the
PLGA/PEO nanoﬁbers instead of crystalline state of isolated ferulic
acid. This also suggested that that drug molecules are uniformly
dispersed in the nanoﬁbers.
3.4. Free radical scavenging activity
DPPH composed of stable free radical molecules with a
maximum optical absorption at 517 nm. It can readily undergo
scavenging by an antioxidant [27,28]. In this study, the antioxidant
activity of isolated ferulic acid and ferulic acid encapsulated PLGA/
PEO nanoﬁbers were recorded to be 41% and 59%, respectively
(Fig. 5). The data showed a signiﬁcant (p  0.05) difference in the
DPPH radical scavenging activity of free ferulic acid and
encapsulated ferulic acid which ensures an improved chemical
integrity and antioxidant activity of ferulic acid after encapsula-
tion.
3.5. In vitro cytotoxicity against HepG2 cells
Hepatocellular carcinoma (HCC) is globally recognized as a
major cancer in the world. HCC is commonly preceded due to the
hepatocellular damage caused by the generation of reactive oxygen
species. Several adjunctive therapies including interferon alpha,
tumor necrosis factor (TNF) and anticancer drugs have been used
to combat HCC [29,30]. However, in spite of enormous progress,
the inherent resistance of cancer cells towards the chemothera-
peutic treatments and augmented level of multi-drug resistance
protein (MDR) are some of the prime obstacles to treat HCC. FerulicFig. 7. The effect of (a) control (b) isolated ferulic acid (c) PLGA/PEO nanoﬁbers and (d) fer
24 h of treatment.acid is one of the well-known phytochemical phenolic for its
anticancer activity against breast cancer colon cancer, skin cancer,
and pulmonary cancer [20,31,32]. The cytotoxicity of ferulic acid
encapsulated PLGA/PEO nanoﬁbers toward HepG2 cells are shown
in Fig. 6. Data revealed that the polymeric nanoﬁbers without
ferulic acid did not display any inhibition in cell growth. Whereas,
the inhibition rate of 51.9% and 71.3% (p < 0.01) in cell growth were
recorded for isolated ferulic acid and ferulic acid encapsulated
nanoﬁbers, respectively.
The morphological changes in hepatoma cells were observed in
presence of isolated ferulic acid and ferulic acid encapsulated
PLGA/PEO nanoﬁbers and shown in Fig. 7. The FESEM images
depicted the normal morphology of hepatoma cells on PLGA/PEO
nanoﬁbers with good adhesion and proliferation. However, a
substantial reduction in cells number and growth was noticed in
case of ferulic acid encapsulated nanoﬁbers. To further determine
the cell cytotoxicity of fabricated nanoﬁbers towards HepG2 cells, a
double staining assay was performed using a mixture of AO and
EtBr in 1:1 w/w ratio. The stained HepG2 cells were visualized
using ﬂuorescent microscopy. Both the dyes (AO, EtBr) mark DNA
and helps in identiﬁcation of live and dead cells. The intact cells
were stained green due to AO whereas the compromised cells
(damaged cells) were stained red due to assimilation of EtBr. The
intercalation of both the dyes gave orange ﬂuorescence [33]. The
cells were found to ﬂuorescence green in case of control and PLGA/
PEO nanoﬁbers (Fig. 8), which conﬁrmed the cytocompatibility of
fabricated PLGA/PEO nanoﬁbers. However, the cells cultured in
presence of isolated ferulic acid and ferulic acid encapsulated
nanoﬁbers accumulated EtBr in their cytoplasm and appeared
yellow–orange due to co-localization of green and red stains.ulicacid encapsulated PLGA/PEO nanoﬁbers on cell morphology of HepG2 cells after
Fig. 8. Fluorescent micrographs of AO:EtBr stained HepG2 cells after 24 h incubation period. (For interpretation of the references to color in the text, the reader is referred to
the web version of this article.)
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acid and ferulic acid encapsulated PLGA/PEO nanoﬁbers against
HepG2 cell line. Moreover, encapsulated ferulic acid possessed
substantial strong cytotoxicity as compared to isolated ferulic acid
alone which suggested that polymeric nanoﬁbrous matrix
efﬁciently helps in maintaining its activity for prolong time.
4. Conclusion
In this study, ferulic acid was isolated from P. hysterophorus by
alkali extraction and its structural characterization was performed
using IR and NMR spectroscopy. To enhance the efﬁciency and
stability of isolated ferulic acid, it was successfully encapsulated in
the PLGA/PEO electrospun nanoﬁbrous matrix. Microscopic
studies revealed the smooth morphology of the fabricated
nanoﬁbers with the predominant distribution of ferulic acid in
the core region of nanoﬁbers. From the data obtained, we can
conclude that the fabricated polymeric nanoﬁbers can act as a
protective layer for ferulic acid and can combat its shortcoming
such as physiochemical stability and premature degradation. In
contrast to isolated ferulic acid, ferulic acid released from PLGA/
PEO nanoﬁbers maintained its cytotoxic activity during the whole
experiment. The formulated ferulic acid encapsulated nanoﬁbers
could be useful in opening up of new therapeutic avenues for liver
cancer.
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